Subscribe to RSS - Mick Farrell

Mick Farrell

ResMed highlights Brightree’s contribution, mask growth in Q3


SAN DIEGO – It was Brightree that pushed ResMed into double-digit increases for revenues in the third quarter of fiscal year 2017.

Integration begins for ResMed

Company acquired Inova, Brightree in less than three-month span

SAN DIEGO – It’s still early days for recent acquisitions to impact ResMed’s financial results, but Inova Technologies helped to boost the company’s revenues by 2% in the third quarter of fiscal year 2016.

ResMed boosts revenue


SAN DIEGO – ResMed reported revenues of $453.9 million for the three months ended March 31, 2016, a 7% increase compared to the same period in 2015. Net income for the quarter was $88.5 million, a 3% decrease compared to the same period in 2015.

Health informatics: ResMed says it has ‘yearlong lead’


SAN DIEGO – The competition in health informatics-driven sleep therapy products is heating up, but ResMed officials say the company is in a good position because it had a head start.

ResMed posts mixed results


SAN DIEGO – ResMed saw a 42% increase in flow generator sales, but a 4% decrease in mask sales for the third quarter ended March 31.

ResMed bets on healthcare informatics


SAN DIEGO – Recent product launches that emphasize connected and data-driven sleep therapy fueled ResMed’s financial results for the second quarter of 2015, CEO Mick Farrell said during a conference call on Jan. 22.

ResMed believes storm has now passed

‘There are green shoots starting to appear’ says CEO Mick Farrell

SAN DIEGO – Competitive bidding helped to drive down ResMed’s revenues in the Americas by 2% for the second quarter ended Dec. 31, 2013, compared to the same period in 2012.

ResMed acknowledges ‘temporary distraction’


SAN DIEGO – Round 2 of competitive bidding has tapped the brakes on ResMed’s growth, officials acknowledged during a conference call Oct. 24 to discuss the company’s first quarter 2014 earnings.

ResMed reports increased income, revenue


SAN DIEGO – ResMed reported net income of $80.9 million for the quarter ended Sept. 30 compared to $71.3 million for the same period last year, a 14% increase.

ResMed 'plans to stay ahead of the game'


SAN DIEGO – Despite pervasive reimbursement pressures, ResMed officials have reported solid earnings for the third quarter and outlined “major growth horizons” for the company’s future.